Masataka Amisaki
- Co-authors
- Soichiro HonjoYoshiyuki FujiwaraNaruo TokuyasuTeruhisa SakamotoHiroaki SaitoHiroyuki TsuchiyaJoji WatanabeTakehiko Hanaki
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Pancreatic and Hepatic Oncology Research (7 papers)Cancer, Lipids, and Metabolism (5 papers)
- Cited by
- HepatologyOncologyCancer Research
- Journals
- SHILAP Revista de lepidopterologíaInternational Journal of Molecular SciencesBiochimica et Biophysica Acta (BBA) - General Subjects
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Masataka Amisaki
34 papers receiving 562 citations
Peers
Comparison fields: 5 of 73
- Oncology 243
- Molecular Biology 157
- Pulmonary and Respiratory Medicine 148
- Surgery 135
- Cancer Research 127
Countries citing papers authored by Masataka Amisaki
This map shows the geographic impact of Masataka Amisaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Amisaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Amisaki more than expected).
Fields of papers citing papers by Masataka Amisaki
This network shows the impact of papers produced by Masataka Amisaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Amisaki. The network helps show where Masataka Amisaki may publish in the future.
Co-authorship network of co-authors of Masataka Amisaki
This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Amisaki. A scholar is included among the top collaborators of Masataka Amisaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Amisaki. Masataka Amisaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 82 | |
| 4 | 1 | |
| 5 | 41 | |
| 6 | 27 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 28 | |
| 10 | 11 | |
| 11 | 12 | |
| 12 | 18 | |
| 13 | 12 | |
| 14 | 17 | |
| 15 | 11 | |
| 16 | 3 | |
| 17 | 4 | |
| 18 | 22 | |
| 19 | 74 | |
| 20 | 16 |
About Masataka Amisaki
Masataka Amisaki is a scholar working on Hepatology, Cancer Research and Oncology, having authored 34 papers that have together received 567 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Hepatology (84 citations), Oncology (243 citations) and Cancer Research (127 citations). Masataka Amisaki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Soichiro Honjo, Yoshiyuki Fujiwara, Naruo Tokuyasu, Teruhisa Sakamoto, Hiroaki Saito, Hiroyuki Tsuchiya, Joji Watanabe, Takehiko Hanaki, Masaki Morimoto and Goshi Shiota. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Biochimica et Biophysica Acta (BBA) - General Subjects.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.